National Institute of Health and Clinical Excellence (NICE) - latest published guidance
NICE is an independent organisation responsible for providing national guidance on promoting good health and preventing and treating ill health. The guidance is developed using the expertise of the NHS and the wider healthcare community including NHS staff, healthcare professionals, patients and carers, industry and the academic world. For more details on their guidance visit their website.
NICE has issued the following guidance to the NHS in England and Wales (September 2012):
- Antibiotics for early-onset neonatal infection
- Bevacizumab in combination with capecitabine for the first-line treatment of metastatic breast cancer
- Lower limb peripheral arterial disease
- Mega Soft Patient Return Electrode for use during monopolar electrosurgery
- Osteoporosis fragility fracture
- SonoVue (sulphur hexafluoride microbubbles) - contrast agent for contrast-enhanced ultrasound imaging of the liver
- Urinary incontinence in neurological disease
Website: National Institute for Health and Clinical Excellence